Navigation Links
Oncotest GmbH and Debiopharm Group Announce a Successful Partnership in the Identification of Biomarker Candidates
Date:4/24/2013

ons, novel combinations of anti-cancer molecules and potential biomarkers are identified using a combination of in vitro and in vivo tests with Oncotest's extensively characterized collection of more than 400 unique patient-derived tumor xenografts (PDX) propagated in nude mice. PDX are known to replicate patient tumor responses to anti-cancer drugs to a high degree. Ex vivo 3D assays are an important component of Oncotest's assay portfolio and standard panels of up to 200 PDX are offered for 3D assay campaigns. Clients benefit from Oncotest's industry leading experience.
Oncotest, based in Freiburg, Germany, was founded in 1993 by Prof. Heiner Fiebig , a clinical oncologist who pioneered the use of PDX for anti-cancer drug discovery and development. The company is focused on preclinical pharmacology of anti-cancer agents and works with large pharmaceutical and biotech companies. http://www.oncotest.de

About Debiopharm Group™

Debiopharm Group™ (Debiopharm) is a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs. The group in-licenses, develops and/or co-develops promising biological and small molecule drug candidates having reached clinical development phases I, II or III, as well as earlier stage candidates. It develops its products for global registration and maximum commercial potential. The products are out-licensed to pharmaceutical partners for sales and marketing. Debiopharm is also active in the field of companion diagnostics with a view to progressing in the area of personalized medicine. Debiopharm independently funds the worldwide development of all of its products while providing expertise in pre-clinical and clinical trials, manufacturing, drug delivery and formulation, and regulatory affairs.

For more information
'/>"/>

SOURCE The Debiopharm Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Debiopharm Announces First Patient Enrolled in Phase III Study for the Rare Disease Central Precocious Puberty
2. MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
3. The SDS/MSA Support Group Officially Changes Name to The Multiple System Atrophy Coalition
4. Many Ginkgo Extracts Safe, Says Herbal Science Group
5. Dr. Vasquez at the Connecticut Plastic Surgery Group Now Offers the Unique Crisalix 3D Simulations for Facial Aesthetics and Breast Augmentation
6. MiMedx Group, Inc. Announces Release Date for 2013 First Quarter Results
7. Dermatology Associates Medical Group in Beverly Hills Announces Safe, Fast Anti-Aging Laser Treatment
8. Atlantica Group LLC to Support International "Soft-Landing" Efforts of Incubators and Accelerators
9. Douglas Harrington, MD Addresses Select Group Of Physicians Regarding Latest Advances In Cardiovascular Risk Assessment
10. EAS Consulting Group, Experts in Quality Regulatory Services Related to FDA Issues, Announces Upcoming Dietary Supplement Seminars in Salt Lake City
11. Cellular Biomedicine Group Appoints Dr. Jianping Dai to the Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... LONDON , July 31, 2014  Smith ... the global medical technology business, today announced its ... of the HAT-TRICK™ Lesser Toe Repair System. Comprised ... includes products for metatarsophalangeal (MTP) ligament repair and ... all-PEEK implant for proximal Inter-phalanges (PIP) fusion, also ...
(Date:7/31/2014)... The global market for molecular diagnostics is expected to ... new study by Grand View Research, Inc. Growing demand ... of advanced cancer diagnostic technologies are expected to be ... years. Moreover, the growing global base of geriatric population ... triggering lifestyle habits such as smoking and excessive alcohol ...
(Date:7/31/2014)... 31, 2014 SoundConnect , ... company, is proud to announce the addition of ... Adobe Connect’s elearning tools to quickly deploy and ... with training tools for desktop and mobile learning ... is the perfect online training solution, enabling organizations ...
(Date:7/30/2014)... , July 30, 2014 Regulus ... biopharmaceutical company leading the discovery and development of innovative ... financial results and highlights for the quarter ended June ... U.S. financial markets close. Regulus will ... 6, 2014, at 5:00 pm Eastern Daylight Time to ...
Breaking Biology Technology:Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 3Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 4Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 2Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 3Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 4Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 5SoundConnect Enhances Portfolio with Adobe Connect Learning Management System (LMS) 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3
... announced that it has been awarded a $1.9 million ... the National Institute of Allergy and Infectious Diseases (NIAID) ... grant will be used to perform additional preclinical toxicology ... hormone product, which is being developed as a potential ...
... SAN MARINO, Calif., Dec. 16 Epeius ... systems, has received,two additional European patents for ... enable precision gene delivery to primary cancers ... body. With profound,demonstrations of clinical benefit and ...
... -- Epitomics, Inc., the world,s sole provider of ... the appointment of Zhiqiang An, Ph.D. as Chief Scientific ... Laboratories, where he was Director of Biologics Research. He ... and development in the biotech and pharmaceutical industries, focusing ...
Cached Biology Technology:Bolder BioTechnology Receives $1.9 Million NIH Grant to Continue Development of Long-Acting Growth Hormone Product 2Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate 2Epitomics Appoints Dr. Zhiqiang An as Chief Scientific Officer 2Epitomics Appoints Dr. Zhiqiang An as Chief Scientific Officer 3
(Date:7/31/2014)... According to the U.S. Census Bureau, Latinos are the ... of the population. Approximately one-third of Latinos are ... obese compared to non-Hispanic Whites. , NYU College ... candidate, has sought to identify the factors that contribute ... qualitative studies that focused on food patterns in Latina ...
(Date:7/31/2014)... Researchers who studied 100 twin pairs have identified a gene ... less than six hours of sleep per night. The ... effects of sleep deprivation. , Results show that a participant ... had an average nightly sleep duration of only five hours, ... twin, who slept for about six hours and five minutes ...
(Date:7/31/2014)... hazard lurks beneath many of the roughly 156,000 ... hazard is corrosion in parts of underground gas ... and contamination of groundwater, a source of drinking ... states have reported many rapidly corroding gas storage ... are generally associated with use of gasoline-ethanol blends ...
Breaking Biology News(10 mins):NYU research looks to combat US Latina immigrant obesity 2Study of twins discovers gene mutation linked to short sleep duration 2NIST corrosion lab tests suggest need for underground gas tank retrofits 2
... . The scientists observed that the impact of ... study have been published in the current online issue of the ... to show that children who are exposed to tobacco smoke prenatally ... of developing abnormal behavioral symptoms when they are of school age," ...
... , WALL, N.J., Dec. 9 ... a leader in finger-based biometric identification solutions, today ... most respected security publications, named BIO-key International the ... Control sub-category Biometrics. , (Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ...
... in old age or diabetes, leads to low blood flow ... tissues. Such blockages can require amputation resulting in loss of ... Hopkins have developed therapies that increase blood flow, improve movement ... findings, published online last week in the early edition of ...
Cached Biology News:Study confirms association between tobacco smoke and behavioral problems in children 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3Gene therapy and stem cells save limb 2Gene therapy and stem cells save limb 3
... Rotor designed for use in the ... Centra-MP4/MP4R*. A translucent lid is included ... rotor design provides excellent chemical resistance ... Polypropylene rotors are fully compatible with ...
Medium bottle for hybridization 250 x 35mm...
Extra Large bottle for hybridization 300 x 70mm...
CQCS kit for first KR 4i , (first unit)....
Biology Products: